nodes	percent_of_prediction	percent_of_DWPC	metapath
Deferoxamine—Corneal opacity—Memantine—Alzheimer's disease	0.0306	0.0306	CcSEcCtD
Deferoxamine—Pyelonephritis—Donepezil—Alzheimer's disease	0.0231	0.0231	CcSEcCtD
Deferoxamine—Retinal disorder—Rivastigmine—Alzheimer's disease	0.0219	0.0219	CcSEcCtD
Deferoxamine—Grand mal convulsion—Donepezil—Alzheimer's disease	0.0185	0.0185	CcSEcCtD
Deferoxamine—Aphasia—Galantamine—Alzheimer's disease	0.0175	0.0175	CcSEcCtD
Deferoxamine—Grand mal convulsion—Memantine—Alzheimer's disease	0.0168	0.0168	CcSEcCtD
Deferoxamine—Transaminases increased—Donepezil—Alzheimer's disease	0.0145	0.0145	CcSEcCtD
Deferoxamine—Aphasia—Donepezil—Alzheimer's disease	0.0136	0.0136	CcSEcCtD
Deferoxamine—Visual acuity reduced—Memantine—Alzheimer's disease	0.0134	0.0134	CcSEcCtD
Deferoxamine—Delusion—Donepezil—Alzheimer's disease	0.0124	0.0124	CcSEcCtD
Deferoxamine—Aphasia—Memantine—Alzheimer's disease	0.0123	0.0123	CcSEcCtD
Deferoxamine—Aphasia—Rivastigmine—Alzheimer's disease	0.012	0.012	CcSEcCtD
Deferoxamine—Cataract—Galantamine—Alzheimer's disease	0.0119	0.0119	CcSEcCtD
Deferoxamine—Bone pain—Galantamine—Alzheimer's disease	0.0118	0.0118	CcSEcCtD
Deferoxamine—Delusion—Memantine—Alzheimer's disease	0.0113	0.0113	CcSEcCtD
Deferoxamine—Delusion—Rivastigmine—Alzheimer's disease	0.011	0.011	CcSEcCtD
Deferoxamine—Cramps of lower extremities—Galantamine—Alzheimer's disease	0.0104	0.0104	CcSEcCtD
Deferoxamine—Cataract—Donepezil—Alzheimer's disease	0.00924	0.00924	CcSEcCtD
Deferoxamine—Bone disorder—Memantine—Alzheimer's disease	0.00884	0.00884	CcSEcCtD
Deferoxamine—Renal impairment—Galantamine—Alzheimer's disease	0.00866	0.00866	CcSEcCtD
Deferoxamine—Bone disorder—Rivastigmine—Alzheimer's disease	0.00865	0.00865	CcSEcCtD
Deferoxamine—Cataract—Memantine—Alzheimer's disease	0.00839	0.00839	CcSEcCtD
Deferoxamine—Bone pain—Memantine—Alzheimer's disease	0.00834	0.00834	CcSEcCtD
Deferoxamine—Cataract—Rivastigmine—Alzheimer's disease	0.00821	0.00821	CcSEcCtD
Deferoxamine—Bone pain—Rivastigmine—Alzheimer's disease	0.00816	0.00816	CcSEcCtD
Deferoxamine—Cramps of lower extremities—Donepezil—Alzheimer's disease	0.00808	0.00808	CcSEcCtD
Deferoxamine—Neuropathy—Memantine—Alzheimer's disease	0.0075	0.0075	CcSEcCtD
Deferoxamine—Neuropathy—Rivastigmine—Alzheimer's disease	0.00733	0.00733	CcSEcCtD
Deferoxamine—Cramps of lower extremities—Rivastigmine—Alzheimer's disease	0.00718	0.00718	CcSEcCtD
Deferoxamine—Abdominal discomfort—Galantamine—Alzheimer's disease	0.00683	0.00683	CcSEcCtD
Deferoxamine—Hepatic function abnormal—Memantine—Alzheimer's disease	0.00663	0.00663	CcSEcCtD
Deferoxamine—Renal failure acute—Memantine—Alzheimer's disease	0.00628	0.00628	CcSEcCtD
Deferoxamine—Renal failure—Galantamine—Alzheimer's disease	0.00624	0.00624	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Galantamine—Alzheimer's disease	0.00622	0.00622	CcSEcCtD
Deferoxamine—Renal failure acute—Rivastigmine—Alzheimer's disease	0.00614	0.00614	CcSEcCtD
Deferoxamine—Renal impairment—Memantine—Alzheimer's disease	0.00609	0.00609	CcSEcCtD
Deferoxamine—Blood creatinine increased—Donepezil—Alzheimer's disease	0.00598	0.00598	CcSEcCtD
Deferoxamine—Renal impairment—Rivastigmine—Alzheimer's disease	0.00596	0.00596	CcSEcCtD
Deferoxamine—Bradycardia—Galantamine—Alzheimer's disease	0.0058	0.0058	CcSEcCtD
Deferoxamine—Hallucination—Galantamine—Alzheimer's disease	0.00567	0.00567	CcSEcCtD
Deferoxamine—Urinary tract disorder—Galantamine—Alzheimer's disease	0.00563	0.00563	CcSEcCtD
Deferoxamine—Connective tissue disorder—Galantamine—Alzheimer's disease	0.0056	0.0056	CcSEcCtD
Deferoxamine—Urethral disorder—Galantamine—Alzheimer's disease	0.00559	0.00559	CcSEcCtD
Deferoxamine—Asthma—Donepezil—Alzheimer's disease	0.00552	0.00552	CcSEcCtD
Deferoxamine—Visual impairment—Galantamine—Alzheimer's disease	0.00549	0.00549	CcSEcCtD
Deferoxamine—Eosinophilia—Donepezil—Alzheimer's disease	0.00546	0.00546	CcSEcCtD
Deferoxamine—Blood creatinine increased—Memantine—Alzheimer's disease	0.00543	0.00543	CcSEcCtD
Deferoxamine—Eye disorder—Galantamine—Alzheimer's disease	0.00533	0.00533	CcSEcCtD
Deferoxamine—Tinnitus—Galantamine—Alzheimer's disease	0.00531	0.00531	CcSEcCtD
Deferoxamine—Abdominal discomfort—Donepezil—Alzheimer's disease	0.00529	0.00529	CcSEcCtD
Deferoxamine—Angiopathy—Galantamine—Alzheimer's disease	0.00517	0.00517	CcSEcCtD
Deferoxamine—Dysuria—Donepezil—Alzheimer's disease	0.00516	0.00516	CcSEcCtD
Deferoxamine—Immune system disorder—Galantamine—Alzheimer's disease	0.00515	0.00515	CcSEcCtD
Deferoxamine—Arrhythmia—Galantamine—Alzheimer's disease	0.00509	0.00509	CcSEcCtD
Deferoxamine—Asthma—Memantine—Alzheimer's disease	0.00501	0.00501	CcSEcCtD
Deferoxamine—Infestation NOS—Donepezil—Alzheimer's disease	0.00492	0.00492	CcSEcCtD
Deferoxamine—Infestation—Donepezil—Alzheimer's disease	0.00492	0.00492	CcSEcCtD
Deferoxamine—Renal failure—Donepezil—Alzheimer's disease	0.00484	0.00484	CcSEcCtD
Deferoxamine—Muscle spasms—Galantamine—Alzheimer's disease	0.00477	0.00477	CcSEcCtD
Deferoxamine—Dysuria—Memantine—Alzheimer's disease	0.00469	0.00469	CcSEcCtD
Deferoxamine—Vision blurred—Galantamine—Alzheimer's disease	0.00468	0.00468	CcSEcCtD
Deferoxamine—Dysuria—Rivastigmine—Alzheimer's disease	0.00458	0.00458	CcSEcCtD
Deferoxamine—Bradycardia—Donepezil—Alzheimer's disease	0.0045	0.0045	CcSEcCtD
Deferoxamine—Infestation—Memantine—Alzheimer's disease	0.00447	0.00447	CcSEcCtD
Deferoxamine—Infestation NOS—Memantine—Alzheimer's disease	0.00447	0.00447	CcSEcCtD
Deferoxamine—Hallucination—Donepezil—Alzheimer's disease	0.00439	0.00439	CcSEcCtD
Deferoxamine—Renal failure—Memantine—Alzheimer's disease	0.00439	0.00439	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Memantine—Alzheimer's disease	0.00438	0.00438	CcSEcCtD
Deferoxamine—Infestation NOS—Rivastigmine—Alzheimer's disease	0.00437	0.00437	CcSEcCtD
Deferoxamine—Infestation—Rivastigmine—Alzheimer's disease	0.00437	0.00437	CcSEcCtD
Deferoxamine—Urinary tract disorder—Donepezil—Alzheimer's disease	0.00436	0.00436	CcSEcCtD
Deferoxamine—Urethral disorder—Donepezil—Alzheimer's disease	0.00433	0.00433	CcSEcCtD
Deferoxamine—Convulsion—Galantamine—Alzheimer's disease	0.0043	0.0043	CcSEcCtD
Deferoxamine—Renal failure—Rivastigmine—Alzheimer's disease	0.0043	0.0043	CcSEcCtD
Deferoxamine—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.00428	0.00428	CcSEcCtD
Deferoxamine—Visual impairment—Donepezil—Alzheimer's disease	0.00426	0.00426	CcSEcCtD
Deferoxamine—Myalgia—Galantamine—Alzheimer's disease	0.00422	0.00422	CcSEcCtD
Deferoxamine—Arthralgia—Galantamine—Alzheimer's disease	0.00422	0.00422	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.00419	0.00419	CcSEcCtD
Deferoxamine—Tinnitus—Donepezil—Alzheimer's disease	0.00412	0.00412	CcSEcCtD
Deferoxamine—Bradycardia—Memantine—Alzheimer's disease	0.00408	0.00408	CcSEcCtD
Deferoxamine—Bradycardia—Rivastigmine—Alzheimer's disease	0.00399	0.00399	CcSEcCtD
Deferoxamine—Hallucination—Memantine—Alzheimer's disease	0.00399	0.00399	CcSEcCtD
Deferoxamine—Shock—Galantamine—Alzheimer's disease	0.00398	0.00398	CcSEcCtD
Deferoxamine—Nervous system disorder—Galantamine—Alzheimer's disease	0.00397	0.00397	CcSEcCtD
Deferoxamine—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00396	0.00396	CcSEcCtD
Deferoxamine—Urinary tract disorder—Memantine—Alzheimer's disease	0.00396	0.00396	CcSEcCtD
Deferoxamine—Tachycardia—Galantamine—Alzheimer's disease	0.00395	0.00395	CcSEcCtD
Deferoxamine—Arrhythmia—Donepezil—Alzheimer's disease	0.00395	0.00395	CcSEcCtD
Deferoxamine—Connective tissue disorder—Memantine—Alzheimer's disease	0.00394	0.00394	CcSEcCtD
Deferoxamine—Skin disorder—Galantamine—Alzheimer's disease	0.00393	0.00393	CcSEcCtD
Deferoxamine—Urethral disorder—Memantine—Alzheimer's disease	0.00393	0.00393	CcSEcCtD
Deferoxamine—Hallucination—Rivastigmine—Alzheimer's disease	0.0039	0.0039	CcSEcCtD
Deferoxamine—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.00387	0.00387	CcSEcCtD
Deferoxamine—Visual impairment—Memantine—Alzheimer's disease	0.00386	0.00386	CcSEcCtD
Deferoxamine—Connective tissue disorder—Rivastigmine—Alzheimer's disease	0.00386	0.00386	CcSEcCtD
Deferoxamine—Urethral disorder—Rivastigmine—Alzheimer's disease	0.00385	0.00385	CcSEcCtD
Deferoxamine—Erythema—Donepezil—Alzheimer's disease	0.00384	0.00384	CcSEcCtD
Deferoxamine—Hypotension—Galantamine—Alzheimer's disease	0.00378	0.00378	CcSEcCtD
Deferoxamine—Visual impairment—Rivastigmine—Alzheimer's disease	0.00378	0.00378	CcSEcCtD
Deferoxamine—Eye disorder—Memantine—Alzheimer's disease	0.00375	0.00375	CcSEcCtD
Deferoxamine—Tinnitus—Memantine—Alzheimer's disease	0.00374	0.00374	CcSEcCtD
Deferoxamine—Muscle spasms—Donepezil—Alzheimer's disease	0.0037	0.0037	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Galantamine—Alzheimer's disease	0.00369	0.00369	CcSEcCtD
Deferoxamine—Eye disorder—Rivastigmine—Alzheimer's disease	0.00367	0.00367	CcSEcCtD
Deferoxamine—Tinnitus—Rivastigmine—Alzheimer's disease	0.00366	0.00366	CcSEcCtD
Deferoxamine—Angiopathy—Memantine—Alzheimer's disease	0.00364	0.00364	CcSEcCtD
Deferoxamine—Paraesthesia—Galantamine—Alzheimer's disease	0.00364	0.00364	CcSEcCtD
Deferoxamine—Vision blurred—Donepezil—Alzheimer's disease	0.00362	0.00362	CcSEcCtD
Deferoxamine—Immune system disorder—Memantine—Alzheimer's disease	0.00362	0.00362	CcSEcCtD
Deferoxamine—Mediastinal disorder—Memantine—Alzheimer's disease	0.00361	0.00361	CcSEcCtD
Deferoxamine—Arrhythmia—Memantine—Alzheimer's disease	0.00358	0.00358	CcSEcCtD
Deferoxamine—Angiopathy—Rivastigmine—Alzheimer's disease	0.00356	0.00356	CcSEcCtD
Deferoxamine—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.00354	0.00354	CcSEcCtD
Deferoxamine—Arrhythmia—Rivastigmine—Alzheimer's disease	0.0035	0.0035	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.0035	0.0035	CcSEcCtD
Deferoxamine—Erythema—Rivastigmine—Alzheimer's disease	0.00342	0.00342	CcSEcCtD
Deferoxamine—Convulsion—Donepezil—Alzheimer's disease	0.00333	0.00333	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.00331	0.00331	CcSEcCtD
Deferoxamine—Vision blurred—Memantine—Alzheimer's disease	0.00329	0.00329	CcSEcCtD
Deferoxamine—Muscle spasms—Rivastigmine—Alzheimer's disease	0.00328	0.00328	CcSEcCtD
Deferoxamine—Arthralgia—Donepezil—Alzheimer's disease	0.00327	0.00327	CcSEcCtD
Deferoxamine—Myalgia—Donepezil—Alzheimer's disease	0.00327	0.00327	CcSEcCtD
Deferoxamine—Vision blurred—Rivastigmine—Alzheimer's disease	0.00322	0.00322	CcSEcCtD
Deferoxamine—Abdominal pain—Galantamine—Alzheimer's disease	0.0032	0.0032	CcSEcCtD
Deferoxamine—Body temperature increased—Galantamine—Alzheimer's disease	0.0032	0.0032	CcSEcCtD
Deferoxamine—Oedema—Donepezil—Alzheimer's disease	0.00314	0.00314	CcSEcCtD
Deferoxamine—Leukopenia—Memantine—Alzheimer's disease	0.00312	0.00312	CcSEcCtD
Deferoxamine—Infection—Donepezil—Alzheimer's disease	0.00312	0.00312	CcSEcCtD
Deferoxamine—Shock—Donepezil—Alzheimer's disease	0.00309	0.00309	CcSEcCtD
Deferoxamine—Nervous system disorder—Donepezil—Alzheimer's disease	0.00308	0.00308	CcSEcCtD
Deferoxamine—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00307	0.00307	CcSEcCtD
Deferoxamine—Convulsion—Memantine—Alzheimer's disease	0.00302	0.00302	CcSEcCtD
Deferoxamine—Hypersensitivity—Galantamine—Alzheimer's disease	0.00298	0.00298	CcSEcCtD
Deferoxamine—Myalgia—Memantine—Alzheimer's disease	0.00297	0.00297	CcSEcCtD
Deferoxamine—Arthralgia—Memantine—Alzheimer's disease	0.00297	0.00297	CcSEcCtD
Deferoxamine—Convulsion—Rivastigmine—Alzheimer's disease	0.00296	0.00296	CcSEcCtD
Deferoxamine—Hypotension—Donepezil—Alzheimer's disease	0.00293	0.00293	CcSEcCtD
Deferoxamine—Arthralgia—Rivastigmine—Alzheimer's disease	0.00291	0.00291	CcSEcCtD
Deferoxamine—Myalgia—Rivastigmine—Alzheimer's disease	0.00291	0.00291	CcSEcCtD
Deferoxamine—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.00289	0.00289	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Donepezil—Alzheimer's disease	0.00286	0.00286	CcSEcCtD
Deferoxamine—Oedema—Memantine—Alzheimer's disease	0.00285	0.00285	CcSEcCtD
Deferoxamine—Infection—Memantine—Alzheimer's disease	0.00283	0.00283	CcSEcCtD
Deferoxamine—Paraesthesia—Donepezil—Alzheimer's disease	0.00282	0.00282	CcSEcCtD
Deferoxamine—Shock—Memantine—Alzheimer's disease	0.0028	0.0028	CcSEcCtD
Deferoxamine—Dyspnoea—Donepezil—Alzheimer's disease	0.0028	0.0028	CcSEcCtD
Deferoxamine—Nervous system disorder—Memantine—Alzheimer's disease	0.00279	0.00279	CcSEcCtD
Deferoxamine—Thrombocytopenia—Memantine—Alzheimer's disease	0.00279	0.00279	CcSEcCtD
Deferoxamine—Oedema—Rivastigmine—Alzheimer's disease	0.00279	0.00279	CcSEcCtD
Deferoxamine—Tachycardia—Memantine—Alzheimer's disease	0.00278	0.00278	CcSEcCtD
Deferoxamine—Diarrhoea—Galantamine—Alzheimer's disease	0.00277	0.00277	CcSEcCtD
Deferoxamine—Infection—Rivastigmine—Alzheimer's disease	0.00277	0.00277	CcSEcCtD
Deferoxamine—Skin disorder—Memantine—Alzheimer's disease	0.00277	0.00277	CcSEcCtD
Deferoxamine—Shock—Rivastigmine—Alzheimer's disease	0.00274	0.00274	CcSEcCtD
Deferoxamine—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.00273	0.00273	CcSEcCtD
Deferoxamine—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.00273	0.00273	CcSEcCtD
Deferoxamine—Tachycardia—Rivastigmine—Alzheimer's disease	0.00272	0.00272	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00271	0.00271	CcSEcCtD
Deferoxamine—Skin disorder—Rivastigmine—Alzheimer's disease	0.00271	0.00271	CcSEcCtD
Deferoxamine—Pain—Donepezil—Alzheimer's disease	0.00268	0.00268	CcSEcCtD
Deferoxamine—Dizziness—Galantamine—Alzheimer's disease	0.00268	0.00268	CcSEcCtD
Deferoxamine—Hypotension—Memantine—Alzheimer's disease	0.00266	0.00266	CcSEcCtD
Deferoxamine—Hypotension—Rivastigmine—Alzheimer's disease	0.0026	0.0026	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Memantine—Alzheimer's disease	0.0026	0.0026	CcSEcCtD
Deferoxamine—Vomiting—Galantamine—Alzheimer's disease	0.00257	0.00257	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.00257	0.00257	CcSEcCtD
Deferoxamine—Paraesthesia—Memantine—Alzheimer's disease	0.00256	0.00256	CcSEcCtD
Deferoxamine—Dyspnoea—Memantine—Alzheimer's disease	0.00254	0.00254	CcSEcCtD
Deferoxamine—Musculoskeletal discomfort—Rivastigmine—Alzheimer's disease	0.00254	0.00254	CcSEcCtD
Deferoxamine—Headache—Galantamine—Alzheimer's disease	0.00254	0.00254	CcSEcCtD
Deferoxamine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.0025	0.0025	CcSEcCtD
Deferoxamine—Urticaria—Donepezil—Alzheimer's disease	0.00249	0.00249	CcSEcCtD
Deferoxamine—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00248	0.00248	CcSEcCtD
Deferoxamine—Abdominal pain—Donepezil—Alzheimer's disease	0.00248	0.00248	CcSEcCtD
Deferoxamine—Body temperature increased—Donepezil—Alzheimer's disease	0.00248	0.00248	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00246	0.00246	CcSEcCtD
Deferoxamine—Pain—Memantine—Alzheimer's disease	0.00244	0.00244	CcSEcCtD
Deferoxamine—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00241	0.00241	CcSEcCtD
Deferoxamine—Nausea—Galantamine—Alzheimer's disease	0.00241	0.00241	CcSEcCtD
Deferoxamine—Pain—Rivastigmine—Alzheimer's disease	0.00238	0.00238	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Memantine—Alzheimer's disease	0.00233	0.00233	CcSEcCtD
Deferoxamine—Hypersensitivity—Donepezil—Alzheimer's disease	0.00231	0.00231	CcSEcCtD
Deferoxamine—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.00228	0.00228	CcSEcCtD
Deferoxamine—Urticaria—Memantine—Alzheimer's disease	0.00226	0.00226	CcSEcCtD
Deferoxamine—Abdominal pain—Memantine—Alzheimer's disease	0.00225	0.00225	CcSEcCtD
Deferoxamine—Body temperature increased—Memantine—Alzheimer's disease	0.00225	0.00225	CcSEcCtD
Deferoxamine—Pruritus—Donepezil—Alzheimer's disease	0.00222	0.00222	CcSEcCtD
Deferoxamine—Urticaria—Rivastigmine—Alzheimer's disease	0.00221	0.00221	CcSEcCtD
Deferoxamine—Body temperature increased—Rivastigmine—Alzheimer's disease	0.0022	0.0022	CcSEcCtD
Deferoxamine—Abdominal pain—Rivastigmine—Alzheimer's disease	0.0022	0.0022	CcSEcCtD
Deferoxamine—Diarrhoea—Donepezil—Alzheimer's disease	0.00215	0.00215	CcSEcCtD
Deferoxamine—Hypersensitivity—Memantine—Alzheimer's disease	0.0021	0.0021	CcSEcCtD
Deferoxamine—Dizziness—Donepezil—Alzheimer's disease	0.00208	0.00208	CcSEcCtD
Deferoxamine—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.00205	0.00205	CcSEcCtD
Deferoxamine—Pruritus—Memantine—Alzheimer's disease	0.00202	0.00202	CcSEcCtD
Deferoxamine—Vomiting—Donepezil—Alzheimer's disease	0.002	0.002	CcSEcCtD
Deferoxamine—Pruritus—Rivastigmine—Alzheimer's disease	0.00197	0.00197	CcSEcCtD
Deferoxamine—Headache—Donepezil—Alzheimer's disease	0.00197	0.00197	CcSEcCtD
Deferoxamine—Diarrhoea—Memantine—Alzheimer's disease	0.00195	0.00195	CcSEcCtD
Deferoxamine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.00191	0.00191	CcSEcCtD
Deferoxamine—Dizziness—Memantine—Alzheimer's disease	0.00188	0.00188	CcSEcCtD
Deferoxamine—Nausea—Donepezil—Alzheimer's disease	0.00186	0.00186	CcSEcCtD
Deferoxamine—Dizziness—Rivastigmine—Alzheimer's disease	0.00184	0.00184	CcSEcCtD
Deferoxamine—Vomiting—Memantine—Alzheimer's disease	0.00181	0.00181	CcSEcCtD
Deferoxamine—Headache—Memantine—Alzheimer's disease	0.00178	0.00178	CcSEcCtD
Deferoxamine—Vomiting—Rivastigmine—Alzheimer's disease	0.00177	0.00177	CcSEcCtD
Deferoxamine—Headache—Rivastigmine—Alzheimer's disease	0.00175	0.00175	CcSEcCtD
Deferoxamine—Nausea—Memantine—Alzheimer's disease	0.00169	0.00169	CcSEcCtD
Deferoxamine—Nausea—Rivastigmine—Alzheimer's disease	0.00166	0.00166	CcSEcCtD
